Clinical Trial Update: Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a multicenter, randomized Phase 2 study comparing mLSG15 plus KW-0761 (mogamulizumab) versus mLSG15 alone in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia Lymphoma

Drugs mentioned

• Poteligeo (mogamulizumab)
• mLSG15 regimen

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Adult T-cell Leukemia-Lymphoma | Phase 2 | Status: COMPLETED